Asensus Surgical
About Asensus Surgical
Asensus Surgical, now a part of the KARL STORZ family, is at the forefront of revolutionizing minimally invasive surgery by integrating advanced digital solutions, robotics, and augmented intelligence (AI). Their core offering, the Senhance Surgical System, and the next-generation LUNA Surgical System, are powered by the Intelligent Surgical Unit (ISU). This technology aims to digitize the interface between the surgeon and the patient, providing capabilities such as machine vision, deep learning, and real-time surgical guidance. The goal is to enhance surgeon control, reduce procedural variability, and ultimately lead to consistently superior patient outcomes in various laparoscopic procedures.
For physicians, the Senhance Surgical System offers features designed to improve the surgical experience and patient care. These include enhanced control through surgeon eye-sensing camera control and 3DHD vision, improved precision via tremor filtration and robotic stabilization, and enhanced focus due to optimized ergonomics and haptic feedback—a first in robotic surgery. The Intelligent Surgical Unit (ISU) captures and analyzes laparoscopic video feeds, delivering actionable, real-time information to surgeons during the procedure. This “Performance-Guided Surgery” approach leverages AI to provide insights beyond traditional robotic capabilities, akin to a GPS system for surgery, which becomes smarter as surgeons build their digital legacy.
Asensus Surgical’s commitment extends to addressing clinical, cognitive, and economic challenges in surgery. Their systems are designed to be cost-effective, utilizing reusable 3mm and 5mm instruments to align with sustainability goals and offer a responsible pricing model similar to traditional laparoscopy. The company’s focus on augmented intelligence and digital surgery platforms aims to make advanced surgical techniques more accessible and predictable, benefiting patients, surgeons, and hospitals worldwide.
Focus Areas
Business Intelligence
| Key Investors | KARL STORZ (acquirer), Aisling Capital, AQR Capital Management, Barclays Global Investors, BlackRock, Bridgeway Capital, Intersouth Partners, Quaker BioVentures, SV Life Science Advisers, Synergy Life Science Partners, Parish Capital Advisors |
| Partnerships | KARL STORZ Group (acquisition), Flex (for LUNA™ Surgical System manufacturing) |
| Acquisitions | KARL STORZ (acquired Asensus Surgical), Senhance Surgical System (acquired from Sofar SPA in 2015), SafeStitch Medical (acquired in 2013) |
| Technology | Senhance® Surgical System, LUNA™ Surgical System (in development), Intelligent Surgical Unit™ (ISU™), Augmented Intelligence, Machine Vision, Deep Learning, Digital Laparoscopy |
| FDA Clearances | Multiple (initial clearance for laparoscopic surgery in 2017, expanded indications for General Surgery in 2021, Pediatric patients in 2023, and Urology in 2024) cleared products (estimated) |
What Physicians Need to Know
For physicians, Asensus Surgical's Senhanceu00ae Surgical System, powered by the Intelligent Surgical Unitu2122 (ISUu2122) and its Augmented Intelligence, offers several key advantages. The system provides real-time, data-driven insights during surgery, helping to lighten cognitive load and support more efficient, precise, and safe medical decisions. Surgeons benefit from enhanced precision and control through robotic manipulation, including selectable scaling and articulating instruments. nnUnique features like haptic feedback transmit forces to the surgeon's hands, providing heightened awareness and an added layer of security. Eye-tracking camera control allows for intuitive navigation of the surgical field, freeing up assistants and enabling the surgeon to maintain focus. The system's improved ergonomics, with a comfortable seated position and an open cockpit, aim to increase surgeon career longevity and facilitate clear communication with the surgical team. nnFurthermore, the use of reusable 3mm and 5mm instruments not only supports less invasive procedures but also offers a responsible per-procedure pricing model similar to traditional laparoscopy. The digital tools for intraoperative measurement (AI Precision) and annotation (AI Annotation) enhance procedural reproducibility and team coordination. The Senhance system is also designed for multi-specialty and multi-quadrant use, applicable in general laparoscopic, gynecological, and colorectal surgeries, and is indicated for both adult and pediatric patients.
Asensus Surgical's Senhanceu00ae Surgical System features an open-platform architecture, allowing for compatibility with 3DHD and HD fluorescence vision systems, as well as integration with other existing hospital investments in laparoscopy. The Intelligent Surgical Unitu2122 (ISUu2122) is designed to integrate with the Senhance System and is compatible with a wide selection of laparoscopic camera platforms. Asensus Surgical has a strategic collaboration with Google Cloud to integrate secure cloud data architecture and machine learning technologies to expand the capabilities of their Performance-Guided Surgery framework. They also partner with KARL STORZ, a global leader in medical technologies, to market and sell the ISU as a standalone device and integrate it into KARL STORZ's laparoscopic vision systems. Eye trackers for the Senhance System are supplied by Tobii. Additionally, Asensus Surgical has partnered with GlobalLogic to develop their next-generation LUNAu2122 robotic surgery system and enhance their intelligent surgical platforms through advanced AI, computer vision, and machine learning.
What the Web Says
Asensus Surgical receives mixed reviews, with some praising its innovative technology and potential for growth in robotic surgery, while others express concerns about product efficacy, company management, and stock performance. The Senhance Surgical System is noted for its augmented intelligence, haptic feedback, eye-tracking camera control, and 3D visualization, along with the use of small-diameter instruments. However, some surgeons have raised issues regarding the ergonomics and articulation of instruments in earlier models. Employer reviews indicate a mixed sentiment regarding work-life balance, pay, and management, with some employees feeling a lack of mutual respect.
Overall: MixedStrengths
- Augmented intelligence and 3D visualization in the Senhance Surgical System.
- Haptic feedback and eye-tracking camera control for enhanced surgical precision.
- Use of 3mm and 5mm instruments, potentially leading to smaller wounds and faster recovery.
- Open console design allowing for clear communication between surgeon and surgical staff.
- Potential for long-term growth in the robotic surgery market.
- Modular robot with an open cockpit appealing to laparoscopic community.
Limitations
- Concerns about the ergonomics and articulation of instruments in earlier product versions.
- Some employees report a lack of mutual respect and issues with management.
- Stock value fluctuations and concerns about profitability.
- The Luna system's unconstrained controllers and cockpit design might be too early for mainstream adoption and could lead to poor surgeon feedback.
- The weight of the Luna system's controllers could be an issue for long procedures.
- Previous product (Senhance) suffered from only having straight instruments for a long time, which is a problem in robotics.
Based on reviews from: YouTube, Indeed.com, Reddit, Medical Device Network
Last updated: 2026-07-19
Videos
News, demos, and interviews about Asensus Surgical.
Videos load interactively. If none appear, search YouTube for Asensus Surgical →
Press & Coverage
Frequently Asked Questions
Related Companies
QuickIntell is an AI-first healthcare technology company dedicated to transforming healthcare operations for physicians and healthcare providers. The company leverages advanced AI agents, including Computer Vision, Machine Learning, Optical Character Recognition (OCR), and Natural Language Processing (NLP), to streamline administrative workflows and enhance Revenue Cycle Management (RCM). QuickIntell’s solutions are designed to reduce administrative burden, […]
Ease Tax Relief, founded in 2016, is a tax relief and resolution company based in Harleysville, PA. The company specializes in helping individuals and small businesses resolve issues with the IRS, offering services such as Offer in Compromise, Partial Pay Installment Agreements, Payment Plans, and Penalty Reduction. Owned and operated by Zheng Yang, a CPA […]
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]